Ingredion reported Q2 2026 net sales of $1.85 billion, up slightly year over year, but operating income declined to $188 million and net income attributable to Ingredion to $114 million ($1.78 diluted EPS) as higher manufacturing costs, a thermal event at its Argo facility, and $45 million of restructuring and impairment charges reduced margins.
For the first half of 2026, net sales were $3.64 billion, operating income $391 million, and net income attributable to Ingredion $256 million ($4.01 diluted EPS), all below 2025, reflecting $56 million of restructuring and impairment (including closure of the Cabo, Brazil facility) and $47 million of acquisition‑related foreign‑exchange hedging losses, partly offset by a $44 million gain on the sale of a majority stake in the Pakistan business.
Ingredion agreed to acquire Tate & Lyle PLC for approximately £2.7 billion (about $3.5 billion), funded with cash, new debt and committed facilities including a $2.75 billion bridge loan and a $1.48 billion delayed‑draw term loan. Tate & Lyle shareholders have approved the court‑sanctioned scheme of arrangement, with completion targeted for the second half of 2027, subject to court and regulatory approvals.
Ingredion ended June 30, 2026 with $948 million of cash and cash equivalents, total debt of $1.78 billion, and stated available liquidity of about $3.9 billion, providing capacity to fund operations, dividends, capital spending and the planned Tate & Lyle transaction.
Ingredion Inc director David B. Fischer sold 1,662 shares of common stock on 2026-08-05 at a weighted average price of $102.31 per share, in multiple trades between $102.13 and $102.55. After this sale, he directly owned 19,929.8698 shares, including RSUs from deemed dividend reinvestment.
Ingredion Incorporated reported second quarter 2026 net sales of $1.85 billion, up 1% year over year, while reported operating income fell 31% to $188 million and adjusted operating income declined 5% to $258 million. Reported diluted EPS decreased to $1.78 from $2.99, with adjusted EPS slipping slightly to $2.82 from $2.87.
Results reflected restructuring and impairment charges tied to the closure of the Cabo, Brazil facility, costs related to a thermal event at the Argo plant, and a $47 million mark-to-market foreign exchange loss on derivatives hedging the pending Tate & Lyle acquisition. Texture & Healthful Solutions delivered 5% net sales and operating income growth to $627 million and $117 million, while Food & Industrial Ingredients–LATAM and –U.S./CAN saw operating income declines of 7% and 33%, respectively, amid currency pressure, softer demand, and earlier Argo production issues that had normalized by quarter-end. The company completed the sale of a majority stake in its Pakistan business, generating a $44 million gain but reducing second-half earnings contribution. For full-year 2026, management reaffirmed guidance for reported EPS of $9.15–$9.75 and adjusted EPS of $10.30–$10.90, expects net sales to be flat to up low single digits, and projects cash from operations of $700–$800 million and capital expenditures of $450–$490 million.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc SVP, Global Ops and CSCO David Eric Seip reported a grant of 17.5600 phantom stock units on July 31, 2026 as a derivative award. These units are allocated under the Non-Qualified Deferred Compensation Plan at the $99.458 closing share price. After this award, he holds 13,377.8931 phantom stock units, each representing the right to receive one share of common stock, including units accumulated through dividend reinvestment.
Ingredion Inc executive Michael J. Leonard, SVP, CIO & Head of Protein Fortification, reported an allocation of 34.343 phantom stock units on July 31, 2026 under the Non-Qualified Deferred Compensation Plan, valued using the $99.462 closing share price. After this report, his phantom stock holdings total 1,801.478 units, including units acquired through dividend reinvestment. Each phantom stock unit represents the right to receive one share of common stock.
First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation report their beneficial ownership of Ingredion Incorporated common stock in an amended Schedule 13G. The group reports beneficial ownership of 2,198,157 shares, representing 3.49% of the outstanding class as of the reporting date.
The filers report no sole voting or dispositive power. They report shared voting power over 1,446,843 shares and shared dispositive power over 2,198,157 shares, largely held in unit investment trusts and other client accounts. Each entity disclaims beneficial ownership of the reported shares, and the filing is made jointly under Rule 13d-1(k)(1). The position is explicitly described as ownership of 5 percent or less of the class.
Ingredion Incorporated reported that on July 28, 2026, its Board of Directors appointed recently elected director Kenneth Escoe to serve on the Audit Committee. Escoe was previously elected to the board in a disclosure dated June 7, 2026, and this amendment updates that disclosure solely to reflect his committee assignment.
Ingredion Incorporated reported progress on its proposed all-cash acquisition of Tate & Lyle PLC. On July 28, 2026, Tate & Lyle shareholders approved the recommended offer for the entire issued and to be issued share capital and passed related implementation resolutions.
The transaction is intended to be carried out through a court-sanctioned scheme of arrangement under Part 26 of the UK Companies Act 2026, following approval at a Court Meeting and a subsequent general meeting. Completion is expected in the second half of 2027, subject to remaining conditions, including material antitrust approvals and sanction of the Scheme by the High Court of Justice in England and Wales.
The company notes this communication is provided under Regulation FD, is not deemed filed for liability purposes, and does not constitute an offer or solicitation; the acquisition will proceed solely under the Scheme or, if elected, a compliant Takeover Offer.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion senior vice president David Eric Seip, SVP, Global Ops and CSCO, received a grant of 17.6120 phantom stock units on July 15, 2026. The units were valued at $99.1640 per unit, based on the closing price of Ingredion common stock. Each phantom stock unit represents the right to receive one share of common stock, for an aggregate allocation of 13,253.7161 phantom stock units under the Non-Qualified Deferred Compensation Plan, held directly.